Drug Research
Nykode Therapeutics and Richter-Helm BioLogics Enter Manufacturing Partnership
Nykode Therapeutics, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, has entered into a manufacturing partnership with Richter-Helm BioLogics to...
News
NHS Cancer Treatment Rates Highest Ever Recorded In 2022
The NHS has released encouraging statistics regarding cancer rates in the UK to kick off the new year. Over the past year, more patients than...
Drug Research
Antibiotic Resistance Being Weakened By Persistent Bacteria
Researchers from Uppsala University in Sweden have released a study on how various antibiotic treatments affect different types of bacteria and how they respond to...
Clinical Trials
CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
CardieX Limited, a global health technology company focused on patient-centric healthcare research and improving clinical trial patient outcomes announced a partnership between its ATCOR subsidiary...
News
Japan’s MHLW approves AstraZeneca’s Imfinzi, Imjudo for liver, lung cancers
The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved AstraZeneca’s immunotherapies Imfinzi (durvalumab) and Imjudo (tremelimumab) to treat advanced liver, biliary tract, and...
News
Cellectis, Primera partner for mitochondrial disease gene therapies
Cellectis has entered into a strategic collaboration agreement with Primera Therapeutics to develop a gene editing platform to treat mitochondrial diseases.
Primera Therapeutics is launched by...
News
BDR Pharma launches first generic apalutamide to treat prostate cancer in India
BDR Pharmaceutical has launched the first generic apalutamide in India to treat both metastatic castration sensitive prostate cancer as well as non-metastatic castration resistant prostate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.